Using Drosophila as our experimental system, we propose employing molecular genetic approaches to identify and characterize genetic modifiers of SMN, as such modifiers may define potential therapeutic targets for Spinal Muscular Atrophy (SMA). The available experimental reagents will allow us to probe tissue-specific (muscle vs. neuron) roles for SMN and its known modifiers at the Drosophila neuromuscular junction (NMJ), and to perform a high-throughput genetic screen to identify modulators of SMN activity using a novel SMN mutation and a unique collection of Drosophila mutations. In view of processes thought to be linked to SMN activity in the muscles and neurons, we propose to characterize functional modifiers of SMN specifically associated with the cytoskeleton and protein translation (Aim 1). In addition, we will further examine our initial observation that FGF signaling activity modifies NMJ abnormalities caused by loss of SMN function. This role will be evaluated in the context of a novel, SMN dependent, muscle deterioration phenotype we uncovered (Aim 2). Finally, we will extend our genetic screens for SMN modifiers using hypomorphic SMN alleles, which provide an improved SMA model and will also use behavioural assays to evaluate the activity of specific adult motorneurons (Aim 3). Our studies will be evaluated in light of a hitherto unprecedented characterization of the Drosophila NMJ (Van Vactor laboratory) while our other collaborative efforts, will permit us to validate results across species in C. elegans (Hart laboratory) and mammalian cells (Rubin laboratory).

National Institute of Health (NIH)
Research Program Projects (P01)
Project #
Application #
Study Section
National Institute of Neurological Disorders and Stroke Initial Review Group (NSD)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Harvard Medical School
United States
Zip Code
Amaral, Andreia J; Brito, Francisco F; Chobanyan, Tamar et al. (2014) Quality assessment and control of tissue specific RNA-seq libraries of Drosophila transgenic RNAi models. Front Genet 5:43
Kwon, Deborah Y; Dimitriadi, Maria; Terzic, Barbara et al. (2013) The E3 ubiquitin ligase mind bomb 1 ubiquitinates and promotes the degradation of survival of motor neuron protein. Mol Biol Cell 24:1863-71
Berke, Brett; Wittnam, Jessica; McNeill, Elizabeth et al. (2013) Retrograde BMP signaling at the synapse: a permissive signal for synapse maturation and activity-dependent plasticity. J Neurosci 33:17937-50
Yang, Yin M; Gupta, Shailesh K; Kim, Kevin J et al. (2013) A small molecule screen in stem-cell-derived motor neurons identifies a kinase inhibitor as a candidate therapeutic for ALS. Cell Stem Cell 12:713-26
Dimitriadi, Maria; Kye, Min Jeong; Kalloo, Geetika et al. (2013) The neuroprotective drug riluzole acts via small conductance Ca2+-activated K+ channels to ameliorate defects in spinal muscular atrophy models. J Neurosci 33:6557-62
Ding, Qiurong; Lee, Youn-Kyoung; Schaefer, Esperance A K et al. (2013) A TALEN genome-editing system for generating human stem cell-based disease models. Cell Stem Cell 12:238-51
Makhortova, Nina R; Hayhurst, Monica; Cerqueira, Antonio et al. (2011) A screen for regulators of survival of motor neuron protein levels. Nat Chem Biol 7:544-52